The Pharmaceutical Company Approach to Antibiotic Policies
Reference31 articles.
1. Appelbaum, P. C., 2003, Bacterial resistance concerns. ASM News, 69(4), 161. 2. Austin, D. J., Kristinsson, K. G., and Anderson, R. M., 1999, The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc. Natl. Acad. Sci. USA, 96, 1152–1156. 3. Ball, P., Baquero, F., Cars, O., File, T., Garau, J., Klugman, K. et al., 2002, Antibiotic therapy of community respiratory tract infections: Strategies for optimal outcomes and minimized resistance emergence. J. Antimicrob. Chemother., 49, 31–40. 4. Bax, R., Bywater, R., Cornaglia, G., Goossens, H., Hunter, P., Isham, V et al., 2001, Surveillance of antimicrobial resistance—what, how and whither? Clin. Microbiol. Infect., 7, 316–325. 5. Bax, R., Gabbay, F., Phillips, I., and the Witley Park Study Group, 1999, Antibiotic clinical trials—the Witley Park Symposium. Clin. Microbiol. Infect., 5, 774–788.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|